Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

15
Number of overlapping holdings
60.0%
% of BBH's 27 holdings also in XBI
11.3%
% of XBI's 134 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in XBI |
Overlap | |
---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 2.8% | 2.8% | 2.8% | |
ALNYLAM PHARMACEUTICALS INC | 4.1% | 2.5% | 2.5% | |
NATERA INC | 4.7% | 2.5% | 2.5% | |
GILEAD SCIENCES INC | 11.7% | 2.5% | 2.5% | |
AMGEN INC | 16.1% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to XBI
AMGEN INC | 13.7% | |
GILEAD SCIENCES INC | 9.3% | |
VERTEX PHARMACEUTICALS INC | 9.0% | |
ARGENX SE ADR | 5.4% | |
IQVIA HOLDINGS INC | 4.5% | |
ILLUMINA INC | 3.9% | |
REGENERON PHARMACEUTICALS | 3.9% | |
ICON PLC | 3.3% | |
BIONTECH SE SPONSORED ADR | 2.7% | |
NATERA INC | 2.3% |
BBH Underweight Relative to XBI
ABBVIE INC | -2.5% | |
VAXCYTE, INC. | -2.3% | |
UNITED THERAPEUTICS CORP | -2.3% | |
HALOZYME THERAPEUTICS INC | -2.1% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.9% | |
TG THERAPEUTICS INC | -1.8% | |
BLUEPRINT MEDICINES CORP. | -1.7% | |
VIKING THERAPEUTICS, INC. | -1.5% | |
BRIDGEBIO PHARMA, INC. | -1.5% | |
ADMA BIOLOGICS, INC. | -1.4% |